One of eight priority areas is substantially enhancing FDA's information technology infrastructure. Better IT will open opportunities to better monitor adverse trends and disease outbreaks; combine data from multiple clinical trials, preclinical work and postmarket studies; evaluate and compare the safety and effectiveness of products; host genomics data; and conduct large scale data- and text-mining for research purposes, according to the agency.
Read more on the FDA's move to better data analytics. Sourced by Information Management
No comments have been posted yet.